GPAT Operating Income from 2010 to 2026
| GPAT Stock | 10.70 0.03 0.28% |
Operating Income | First Reported 2010-12-31 | Previous Quarter -508.5 K | Current Value -483.1 K | Quarterly Volatility 201.3 K |
Check GP Act financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GP Act's main balance sheet or income statement drivers, such as Other Operating Expenses of 682.2 K, Ebitda of 10.5 M or Total Operating Expenses of 682.2 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.41. GPAT financial statements analysis is a perfect complement when working with GP Act Valuation or Volatility modules.
GPAT | Operating Income | Build AI portfolio with GPAT Stock |
Latest GP Act's Operating Income Growth Pattern
Below is the plot of the Operating Income of GP Act III Acquisition over the last few years. Operating Income is the amount of profit realized from GP Act III operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of GP Act III Acquisition is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. GP Act's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GP Act's overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
GPAT Operating Income Regression Statistics
| Arithmetic Mean | (98,586) | |
| Coefficient Of Variation | (204.16) | |
| Mean Deviation | 148,331 | |
| Median | (3,970) | |
| Standard Deviation | 201,278 | |
| Sample Variance | 40.5B | |
| Range | 561K | |
| R-Value | (0.67) | |
| Mean Square Error | 23.6B | |
| R-Squared | 0.45 | |
| Significance | 0 | |
| Slope | (26,885) | |
| Total Sum of Squares | 648.2B |
GPAT Operating Income History
About GP Act Financial Statements
GP Act shareholders use historical fundamental indicators, such as Operating Income, to determine how well the company is positioned to perform in the future. Although GP Act investors may analyze each financial statement separately, they are all interrelated. The changes in GP Act's assets and liabilities, for example, are also reflected in the revenues and expenses on on GP Act's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Income | -508.5 K | -483.1 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GPAT Stock Analysis
When running GP Act's price analysis, check to measure GP Act's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GP Act is operating at the current time. Most of GP Act's value examination focuses on studying past and present price action to predict the probability of GP Act's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GP Act's price. Additionally, you may evaluate how the addition of GP Act to your portfolios can decrease your overall portfolio volatility.